Pierandrea Muglia
Direttore/Membro del Consiglio presso SANA AB
Profilo
Pierandrea Muglia is an Independent Director at Saniona AB since 2023.
Previously, he worked as the Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A and as the Chief Marketing Officer at Handl Therapeutics BV.
Posizioni attive di Pierandrea Muglia
| Società | Posizione | Inizio |
|---|---|---|
| SANA AB | Direttore/Membro del Consiglio | 01/01/2023 |
Precedenti posizioni note di Pierandrea Muglia
| Società | Posizione | Fine |
|---|---|---|
| GRIN Therapeutics, Inc. | Fondatore | 01/09/2022 |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 01/10/2019 |
Handl Therapeutics BV
 Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Vendite & Marketing | - |
| NTG NORDIC TRANSPORT GROUP A/S | Direttore/Membro del Consiglio | 28/05/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| SANA AB | Health Technology |
| Aziende private | 3 |
|---|---|
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Health Technology |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Health Technology |
| GRIN Therapeutics, Inc. |
- Borsa valori
- Insiders
- Pierandrea Muglia
